Literature DB >> 8895490

p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons.

Y Kazachkov1, V Khaoustov, B Yoffe, H Solomon, G B Klintmalm, E Tabor.   

Abstract

Mutations of the tumor suppressor gene p53 have been found in hepatocellular carcinomas (HCCs) from many countries where HCC is common, but p53 mutations detected by direct sequencing in HCCs from the United States (where HCC is uncommon) have been reported only rarely. p53 Exons 1 to 11 were analyzed by polymerase chain reaction, single-strand conformation polymorphism analysis, and direct sequencing in HCCs from 12 patients from the United States and in adjacent non-tumorous liver from 10 of them. Abnormalities of the p53 gene were found in five of the 12 tumors, including mutations in exon 4 (one patient), exon 5 (one patient) and exon 8 (three patients). In all 12 tumors, a normal conformation of exon 7 was found; in five of these HCCs the absence of mutations was confirmed by direct sequencing. Thus, the mutations of p53 codon 249 that have frequently been found in HCCs from endemic areas apparently do not play a role in most HCCs in the United States. Since the mutations in codon 249 are thought to be due to aflatoxin ingestion, the data suggest that factors other than aflatoxin may be responsible for the p53 abnormalities in the patients from the USA.

Entities:  

Mesh:

Year:  1996        PMID: 8895490     DOI: 10.1093/carcin/17.10.2207

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

Authors:  Bin Yang; Mingzhou Guo; James G Herman; Douglas P Clark
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

2.  Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.

Authors:  M Mihara; Y Nimura; S Ichimiya; S Sakiyama; S Kajikawa; W Adachi; J Amano; A Nakagawara
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

3.  Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation.

Authors:  C Vivo; C Lecomte; F Levy; K Leroy; Y Kirova; A Renier; L Kheuang; P Piedbois; D Chopin; M C Jaurand
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.